logo

HDFC Pharma and Healthcare Reg Gr

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

HDFC Pharma and Healthcare Reg Gr

as of 22 Jul 2026, 18:51 PM

Scheme Asset Size₹2611.33 Cr
Expense Ratio2.16%
Cash Holding2.77147%
Fund TypeOpen-End
PlanGrowth
BenchmarkBSE Healthcare TR INR
Launch Date2023-10-04
Exit LoadExit load of 1.00% for investments if redeemed within 30 Days

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months 5.43%
In the last 3 months 18.06%
In the last 6 months 27.84%
In the last 1 Years 19.89%
In the last 3 Years 0.00%
In the last 5 Years 0.00%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE9.96%
Divi's Laboratories LtdHealthcareE7.16%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE5.57%
Lupin LtdHealthcareE5.26%
Cipla LtdHealthcareE5.19%
Aster DM Quality Care Ltd Ordinary SharesHealthcareE5.05%
Acutaas Chemicals LtdBasic MaterialsE4.58%
Alkem Laboratories LtdHealthcareE4.00%
Anthem Biosciences LtdHealthcareE3.81%
Ipca Laboratories LtdHealthcareE3.53%
Fortis Healthcare LtdHealthcareE3.18%
Global Health LtdHealthcareE3.08%
Krishna Institute of Medical Sciences LtdHealthcareE3.07%
Neuland Laboratories LtdHealthcareE2.93%
Glenmark Pharmaceuticals LtdHealthcareE2.88%
Vijaya Diagnostic Centre LtdHealthcareE2.53%
Shilpa Medicare LtdHealthcareE2.48%
Zydus Lifesciences LtdHealthcareE2.34%
Metropolis Healthcare LtdHealthcareE2.24%
Wockhardt LtdHealthcareE2.11%
Sai Life Sciences LtdHealthcareE1.71%
Rubicon Research LtdHealthcareE1.70%
Thyrocare Technologies LtdHealthcareE1.51%
Eris Lifesciences Ltd Registered ShsHealthcareE1.49%
Ajanta Pharma LtdHealthcareE1.42%
Corona Remedies LtdHealthcareE1.31%
Gland Pharma LtdHealthcareE1.20%
Jubilant Pharmova LtdHealthcareE1.18%
Biocon LtdHealthcareE1.17%
Dr Reddy's Laboratories LtdHealthcareE1.04%
Bajaj Healthcare LtdHealthcareE0.77%
Laxmi Dental LtdHealthcareE0.56%
Novartis India LtdHealthcareE0.53%
Cohance Lifesciences LtdHealthcareE0.44%
Jupiter Life Line Hospitals LtdHealthcareE0.27%
Treps - Tri-Party Repo-CR3.32%
Net Current Assets-C0.54%
Laurus Labs Ltd-E-

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

97.23%

Cash

2.77%

Equity sector allocation

Loading chart…

Basic Materials

4.58%

Healthcare

92.65%

Others

2.77%

Fund House Contact Details

Websitewww.hdfcfund.com
Phone+91 22 66316333
Logo
HDFC Asset Management Co Ltd

Asset Management Company

About HDFC Pharma and Healthcare Reg Gr

Investment Objective of the Scheme

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Key Features of The Fund

5-year return

-

Fund Manager

Dhruv Muchhal

Risk Profile

Very High Risk

Expense Ratio

2.16%

Fund Size

₹2611.33 Cr

HDFC Pharma and Healthcare Reg Gr Summary

HDFC Pharma and Healthcare Reg Gr NAV, Returns, Performance & Details

HDFC Pharma and Healthcare Reg Gr is currently priced at ₹21.04, as of 22 Jul 2026, 18:51 PM. The fund has recorded a change of ₹0.04 (0.17%), indicating its recent movement in the market.

Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.

HDFC Pharma and Healthcare Reg Gr Fund Details and Key Information

HDFC Pharma and Healthcare Reg Gr is an open-ended mutual fund that invests based on its stated objective and benchmark.

Key details:

  • Asset Size: ₹2611.33 Cr

  • Expense Ratio: 2.16%

  • Cash Holding: 2.77%

  • Plan Type: Growth

  • Benchmark: BSE Healthcare TR INR

  • Launch Date: 2023-10-04

  • Exit Load: 1.00

These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.

HDFC Pharma and Healthcare Reg Gr Returns and Performance

HDFC Pharma and Healthcare Reg Gr has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.

Returns:

  • 1 Month: 5.43%

  • 3 Months: 18.06%

  • 6 Months: 27.84%

  • 1 Year: 19.89%

  • 3 Years: -

  • 5 Years: -

Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.

HDFC Pharma and Healthcare Reg Gr Risk Level and Volatility

Understanding risk is important before investing. HDFC Pharma and Healthcare Reg Gr falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.

Risk Level: Very High Risk

The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.

HDFC Pharma and Healthcare Reg Gr Portfolio Allocation

The asset allocation of HDFC Pharma and Healthcare Reg Gr shows how investments are distributed across asset classes.

  • Equity Allocation: 97.23%

  • Cash Allocation: 2.77%

This allocation plays a key role in determining the fund’s risk and return profile.

HDFC Pharma and Healthcare Reg Gr Sector Allocation

HDFC Pharma and Healthcare Reg Gr diversifies its investments across sectors to reduce risk.

Sector Holding Detail

  • Basic Materials: 4.58%

  • Healthcare: 92.65%

Sector allocation data helps investors understand which industries the fund is focusing on.

HDFC Pharma and Healthcare Reg Gr Fund House

HDFC Pharma and Healthcare Reg Gr is managed by:

AMC Name: HDFC Asset Management Co Ltd

A strong fund house with a proven track record can improve investor confidence.

HDFC Pharma and Healthcare Reg Gr Minimum Investment

Investors can start investing in HDFC Pharma and Healthcare Reg Gr with:

Minimum Investment: ₹100

This makes the fund accessible for both beginners and experienced investors.

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy